BB Biotech's total assets for Q1 2025 were CHF1.95B, a decrease of -19.05% from the previous quarter. CH:BION total liabilities were CHF4.42M for the fiscal quarter, a -96.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.